Global Anticoagulant Reversal Drugs Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 99

Report ID: 5380

North America and Europe, cumulatively, accounted for over 70% share of the global market in 2018.
In 2018, the global Anticoagulant Reversal Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Anticoagulant Reversal Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anticoagulant Reversal Drugs development in United States, Europe and China.

The key players covered in this study
Pfizer
Bausch Health Companies
Fresenius
Boehringer Ingelheim
Amneal Pharmaceuticals
CSL Limited
Octapharma AG
Portola Pharmaceuticals
AMAG Pharmaceuticals

Market segment by Type, the product can be split into
Prothrombin Complex Concentrates (PCC)
Vitamin K
Protamine
Tranexamic Acid
Idarucizumab
Others

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Anticoagulant Reversal Drugs status, future forecast, growth opportunity, key market and key players.
To present the Anticoagulant Reversal Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Anticoagulant Reversal Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Anticoagulant Reversal Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Prothrombin Complex Concentrates (PCC)
1.4.3 Vitamin K
1.4.4 Protamine
1.4.5 Tranexamic Acid
1.4.6 Idarucizumab
1.4.7 Others
1.5 Market by Application
1.5.1 Global Anticoagulant Reversal Drugs Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Anticoagulant Reversal Drugs Market Size
2.2 Anticoagulant Reversal Drugs Growth Trends by Regions
2.2.1 Anticoagulant Reversal Drugs Market Size by Regions (2014-2025)
2.2.2 Anticoagulant Reversal Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Anticoagulant Reversal Drugs Market Size by Manufacturers
3.1.1 Global Anticoagulant Reversal Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Anticoagulant Reversal Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Anticoagulant Reversal Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Anticoagulant Reversal Drugs Key Players Head office and Area Served
3.3 Key Players Anticoagulant Reversal Drugs Product/Solution/Service
3.4 Date of Enter into Anticoagulant Reversal Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Anticoagulant Reversal Drugs Market Size by Type (2014-2019)
4.2 Global Anticoagulant Reversal Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Anticoagulant Reversal Drugs Market Size (2014-2019)
5.2 Anticoagulant Reversal Drugs Key Players in United States
5.3 United States Anticoagulant Reversal Drugs Market Size by Type
5.4 United States Anticoagulant Reversal Drugs Market Size by Application

6 Europe
6.1 Europe Anticoagulant Reversal Drugs Market Size (2014-2019)
6.2 Anticoagulant Reversal Drugs Key Players in Europe
6.3 Europe Anticoagulant Reversal Drugs Market Size by Type
6.4 Europe Anticoagulant Reversal Drugs Market Size by Application

7 China
7.1 China Anticoagulant Reversal Drugs Market Size (2014-2019)
7.2 Anticoagulant Reversal Drugs Key Players in China
7.3 China Anticoagulant Reversal Drugs Market Size by Type
7.4 China Anticoagulant Reversal Drugs Market Size by Application

8 Japan
8.1 Japan Anticoagulant Reversal Drugs Market Size (2014-2019)
8.2 Anticoagulant Reversal Drugs Key Players in Japan
8.3 Japan Anticoagulant Reversal Drugs Market Size by Type
8.4 Japan Anticoagulant Reversal Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Anticoagulant Reversal Drugs Market Size (2014-2019)
9.2 Anticoagulant Reversal Drugs Key Players in Southeast Asia
9.3 Southeast Asia Anticoagulant Reversal Drugs Market Size by Type
9.4 Southeast Asia Anticoagulant Reversal Drugs Market Size by Application

10 India
10.1 India Anticoagulant Reversal Drugs Market Size (2014-2019)
10.2 Anticoagulant Reversal Drugs Key Players in India
10.3 India Anticoagulant Reversal Drugs Market Size by Type
10.4 India Anticoagulant Reversal Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Anticoagulant Reversal Drugs Market Size (2014-2019)
11.2 Anticoagulant Reversal Drugs Key Players in Central & South America
11.3 Central & South America Anticoagulant Reversal Drugs Market Size by Type
11.4 Central & South America Anticoagulant Reversal Drugs Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Anticoagulant Reversal Drugs Introduction
12.1.4 Pfizer Revenue in Anticoagulant Reversal Drugs Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Bausch Health Companies
12.2.1 Bausch Health Companies Company Details
12.2.2 Company Description and Business Overview
12.2.3 Anticoagulant Reversal Drugs Introduction
12.2.4 Bausch Health Companies Revenue in Anticoagulant Reversal Drugs Business (2014-2019)
12.2.5 Bausch Health Companies Recent Development
12.3 Fresenius
12.3.1 Fresenius Company Details
12.3.2 Company Description and Business Overview
12.3.3 Anticoagulant Reversal Drugs Introduction
12.3.4 Fresenius Revenue in Anticoagulant Reversal Drugs Business (2014-2019)
12.3.5 Fresenius Recent Development
12.4 Boehringer Ingelheim
12.4.1 Boehringer Ingelheim Company Details
12.4.2 Company Description and Business Overview
12.4.3 Anticoagulant Reversal Drugs Introduction
12.4.4 Boehringer Ingelheim Revenue in Anticoagulant Reversal Drugs Business (2014-2019)
12.4.5 Boehringer Ingelheim Recent Development
12.5 Amneal Pharmaceuticals
12.5.1 Amneal Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Anticoagulant Reversal Drugs Introduction
12.5.4 Amneal Pharmaceuticals Revenue in Anticoagulant Reversal Drugs Business (2014-2019)
12.5.5 Amneal Pharmaceuticals Recent Development
12.6 CSL Limited
12.6.1 CSL Limited Company Details
12.6.2 Company Description and Business Overview
12.6.3 Anticoagulant Reversal Drugs Introduction
12.6.4 CSL Limited Revenue in Anticoagulant Reversal Drugs Business (2014-2019)
12.6.5 CSL Limited Recent Development
12.7 Octapharma AG
12.7.1 Octapharma AG Company Details
12.7.2 Company Description and Business Overview
12.7.3 Anticoagulant Reversal Drugs Introduction
12.7.4 Octapharma AG Revenue in Anticoagulant Reversal Drugs Business (2014-2019)
12.7.5 Octapharma AG Recent Development
12.8 Portola Pharmaceuticals
12.8.1 Portola Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Anticoagulant Reversal Drugs Introduction
12.8.4 Portola Pharmaceuticals Revenue in Anticoagulant Reversal Drugs Business (2014-2019)
12.8.5 Portola Pharmaceuticals Recent Development
12.9 AMAG Pharmaceuticals
12.9.1 AMAG Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Anticoagulant Reversal Drugs Introduction
12.9.4 AMAG Pharmaceuticals Revenue in Anticoagulant Reversal Drugs Business (2014-2019)
12.9.5 AMAG Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details